The global NASH biomarkers market is anticipated to grow significantly at a CAGR of 28.6% during the forecast period. The growing number of hepatitis with obesity and other chronic liver disease is growing the global Non-alcoholic Steatohepatitis Biomarkers market. Hepatitis is an inflammation of the liver that is caused by a variety of infectious viruses […]